Alchem Laboratories specializes in custom synthesis and has a robust track record in the manufacturing of active pharmaceutical ingredients (APIs) and drug products, having supported over 80 clinical trials in the past decade. Their focus includes a variety of clinical studies, particularly in oncology, where they have developed treatments such as Endoxifen for breast cancer and Triapine for various cancers. The company is dedicated to advancing drug discovery and development, showcasing their commitment to excellence in the pharmaceutical industry.

The Alchem-DCI facility is equipped with advanced technologies that facilitate preclinical drug discovery, including ultra-high throughput screening (uHTS) and assay development for various target types. Their capabilities encompass a wide range of activities, from hit-to-lead optimization to pharmacology studies, supported by a significant collection of molecular compounds. Key resources include fully integrated robotic systems and sophisticated instrumentation for high-content screening, which enhance their ability to conduct comprehensive drug discovery research and contribute to the development of new therapeutic options.

United States

Alchem Laboratories is a pharmaceutical company that specializes in custom organic synthesis, cGMP manufacturing, and analytical services.

Alchem Laboratories

Company Details